Call Number (LC) Title Results
RM301.41 .C36 1995 Perspectives in receptor research : proceedings of the 10th Camerino-Noordwijkerhout Symposium, Camerino, Italy, 10-14 September 1996 / 1
RM301.41 .N66 1993 Trends in drug research : proceedings of the 9th Noordwijkerhout-Camerino Symposium, Noordwijkerhout, the Netherlands, 23-28 May 1993 / 1
RM 301.41 .R39 1998 Receptor-based drug design / 1
RM301.41 .R39 1998 Receptor-based drug design / 1
RM 301.41 .R43 2000 Receptor chemistry towards the third millennium : proceedings of the 12th Camerino-Noordwijkerhout Symposium, Camerino, Italy, 5-9 September 1999 / 1
RM 301.41 .S58 1995 Sites of drug action in the human brain / 1
RM301.41 .S58 1995 Sites of drug action in the human brain / 1
RM301.41 .T486 2015eb Textbook of receptor pharmacology / 1
RM 301.42 .A143 1993 3D QSAR in drug design : theory, methods and applications / 1
RM301.42 .A384 2013 Frontiers in Clinical Drug Research - Anti-Allergy Agents. 1
RM301.42 .C37 1993 The steric factor in medicinal chemistry : dissymmetric probes of pharmacological receptors / 1
RM301.42 .E88 1990 QSAR, rational approaches to the design of bioactive compounds : proceedings of the VIII European Symposium on Quantitative Structure-Activity Relationships, Sorrento, Italy, 9-13 September 1990 / 1
RM301.42 .F384 2011 Frontiers in Drug Design & Discovery Volume 5. 1
RM301.42 .M65 2008 Molecular drug properties : measurement and prediction / 1
RM301.42 .Q28 1995 QSAR and drug design : new developments and applications / 1
RM301.42 .S49 2002 Drug membrane interactions : analysis, drug distribution, modeling / 1
RM301.45 .A66 Approved drug products with therapeutic equivalence evaluations orange book.
Approved drug products with therapeutic equivalence evaluations.
2
RM301.45 .A66 1985- Approved drug products with therapeutic equivalence evaluations. 1
RM301.45 .A796 2015 Arzneimitteltherapiesicherheit im Spannungsfeld von vollständiger Medikationsübersicht, mündigem Patienten und individualisierter Medikation. 1
RM301.45 .G42 2008 Generic drug product development : bioequivalence issues / 1